FilingReader Intelligence
Nhwa Pharmaceutical to cancel restricted stocks, reducing capital
June 13, 2025 at 05:24 PM UTC•By FilingReader AI
Jiangsu Nhwa Pharmaceutical (SZSE:002262) announced its plan to reduce its registered capital by cancelling 390,209 restricted stocks, repurchased at a price of CNY11.15 per share, totaling CNY4,350,830.35. The decision, approved at the company's recent shareholder meeting on June 13, will decrease the registered capital from CNY101,617,679.2 to CNY101,578,658.3.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
SZSE:002262•Shenzhen Stock Exchange
News Alerts
Get instant email alerts when Jiangsu Nhwa Pharmaceutical publishes news
Free account required • Unsubscribe anytime